.Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AK06_SalmeterolAndFluticasone.SalmeterolAndFluticasone .Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AK06_SalmeterolAndFluticasone.SalmeterolAndFluticasone| name: | SalmeterolAndFluticasone | |
| ATC code: | R03AK06 | route: | inhalation |
| compartments: | 2 | |
| dosage: | 50 | mg |
| volume of distribution: | 183 | L |
| clearance: | 1.15 | L/min |
| other parameters in model implementation | ||
Salmeterol and fluticasone is an inhaled fixed-dose combination medication used for long-term maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting beta-2 agonist that acts as a bronchodilator, and fluticasone is an inhaled corticosteroid with anti-inflammatory properties. The combination is approved and widely used.
Pharmacokinetic estimates for healthy adults based on published studies of the combination via inhaled route.